FDA advisers object to Alzheimer’s drug aducanumab ahead of final decision
The experimental Alzheimer’s drug aducanumab is not ready for federal approval in June, advisers to the Food and Drug Administration say in a new JAMA editorial.
The experimental Alzheimer’s drug aducanumab is not ready for federal approval in June, advisers to the Food and Drug Administration say in a new JAMA editorial.
Alzheimer’s Disease is increasingly being referred to as insulin resistance of the brain, or Type 3 diabetes, a research team says.
Greater physical activity at the study’s start appeared to lessen gene-related cognitive decline two years later, the authors report.
Thirty-day COVID mortality declines in nationwide elder veterans study … Women accumulate Alzheimer’s tau protein in the brain faster than men, research shows … Nearly all healthcare workers have a strong immune response to one Pfizer vaccine dose in new study … GSK seeks emergency use approval for its antibody drug after trial success
End-of-life hospitalization risk among Black residents with severe cognitive impairment is persistently elevated both within and between facilities, a study of long-stay residents shows.
AHCA / NCAL’s #GetVaccinated.us website is up and running … ‘Fear visuals’ may be keeping needle-phobic from getting vaccinated … Psychiatric diagnoses tied to lower age of Alzheimer’s onset … New lung cancer screening guidelines expand access; critics say it’s not enough
A large study from Canada has found disparities in palliative care referral between people with dementia or organ failure and people with cancer.
People with anxiety or depression and Alzheimer’s may show dementia symptoms two to three years earlier than their peers without these diagnoses, researchers say.
Dementia care report should be ‘catalyst for change,’ committee says … Pain perception may be early disease marker in Alzheimer’s gene carriers … Nursing home first-dose vaccination data released for federal Pharmacy Partnership for Long-Term Care Program … HHS to stop allocating antibody drugs as supplies increase … New U.S. COVID-19 vaccine index contains county-level insight
An experimental drug meant to treat the “type 3 diabetes” that some scientists believe triggers Alzheimer’s has been approved for a late-stage clinical trial.